RR-A3

Available dosages: 10mg, 5mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg

Product Description

RR-A3 is a novel triple-agonist peptide targeting multiple metabolic receptors simultaneously. This innovative compound represents the next generation of incretin-based research molecules. Studies have shown remarkable effects on metabolic parameters and energy homeostasis. Our RR-A3 is synthesized using advanced peptide manufacturing techniques with rigorous quality control.

Key Research Areas

• Triple receptor agonist mechanism
• GLP-1/GIP/Glucagon pathway research
• Advanced metabolic studies
• Next-gen incretin investigation

Quality Assurance

All RR-A3 batches are third-party tested with Certificates of Analysis available for verification.

For research use only. Not for human consumption.